JAMA Ophthalmology Viewpoint Examines Impact of China’s Red Light Therapy Regulations
Manufacturers now face significant challenges in bringing RLRL instruments to market under the new Class III medical device classification. Penned…
Manufacturers now face significant challenges in bringing RLRL instruments to market under the new Class III medical device classification. Penned…